Analysis of lipid peroxidation biomarkers in extremely low gestational age neonate urines by UPLC-MS/MS

Analytical and Bioanalytical Chemistry

Volumn 406, Issue 18, 2014, Pages 4345-4356

  Kuligowski, Julia ^a   Escobar, Javier ^a   Quintás, Guillermo ^b   Lliso, Isabel ^a   Torres Cuevas, Isabel ^a   Nuñez, Antonio ^a   Cubells, Elena ^a   Rook, Denise ^c   Van Goudoever, Johannes B ^c,d,e   Vento, Máximo ^a,f  

^a INSTITUTO DE INVESTIGACIÓN SANITARIA DEL HOSPITAL CLÍNICO SAN CARLOS IDISSC   (Spain)

^b LEITAT TECHNOLOGICAL CENTER   (Spain)

^c SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e EMMA CHILDREN S HOSPITAL   (Netherlands)

^f HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Extremely low gestational age newborn (ELGAN); Isoprostanes; Lipid peroxidation; Liquid chromatography tandem mass spectrometry (LC MS MS); Method validation; Oxidative stress

Indexed keywords

INDUCTIVELY COUPLED PLASMA; ISOTOPES; LIPIDS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; RESUSCITATION;

GESTATIONAL AGE; ISOPROSTANES; LIPID PEROXIDATION; LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY (LC MS/MS); METHOD VALIDATIONS;

OXIDATIVE STRESS;

BIOLOGICAL MARKER; ISOPROSTANE DERIVATIVE; PROSTAGLANDIN;

FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPID PEROXIDATION; MALE; NEWBORN; PREMATURITY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFERENCE VALUE; REPRODUCIBILITY; TANDEM MASS SPECTROMETRY; URINE;

BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; ISOPROSTANES; LIPID PEROXIDATION; MALE; PROSTAGLANDINS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY;

EID: 84903751200     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-014-7824-6     Document Type: Article

References (40)

1. Maltepe E, Saugstad OD (2009) Oxygen in health and disease: regulation of oxygen homeostasis-clinical implications. Pediatr Res 65:261-268
2. Vento M, Aguar M, Escobar J et al (2009) Antenatal steroids and antioxidant enzyme activity in preterm infants: influence of gender and timing. Antioxid Redox Signal 11:2945-2955. doi: 10.1089/ars.2009.2671
3. Friel JK, Friesen RW, Harding SV, Roberts LJ (2004) Evidence of oxidative stress in full-term healthy infants. Pediatr Res 56:878-882. doi: 10.1203/01.PDR.0000146032.98120.43
4. Vento M, Escobar J, Cernada M et al (2012) The use and misuse of oxygen during the neonatal period. Clin Perinatol 39:165. doi: 10.1016/j.clp.2011.12. 014
5. Dawson JA, Kamlin COF, Vento M et al (2010) Defining the reference range for oxygen saturation for infants after birth. Pediatrics 125:E1340-E1347. doi: 10.1542/peds.2009-1510
6. Vento M, Saugstad OD (2011) Oxygen supplementation in the delivery room: updated information. J Pediatr 158:e5-e7. doi: 10.1016/j.jpeds.2010.11.004
7. Saugstad OD, Sejersted Y, Solberg R et al (2012) Oxygenation of the newborn: a molecular approach. Neonatology 101:315-325. doi: 10.1159/000337345
8. Perlman JM, Wyllie J, Kattwinkel J et al (2010) Part 11: Neonatal resuscitation: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation 122:S516-S538. doi: 10.1161/CIRCULATIONAHA.110.971127
9. Brown JVE, Moe-Byrne T, Harden M, McGuire W (2012) Lower versus higher oxygen concentration for delivery room stabilisation of preterm neonates: systematic review. PLoS One 7:e52033. doi: 10.1371/journal.pone.0052033
10. Halliwell B, Whiteman M (2004) Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 142:231-255. doi: 10.1038/sj.bjp.0705776
11. Guéraud F, Atalay M, Bresgen N et al (2010) Chemistry and biochemistry of lipid peroxidation products. Free Radic Res 44:1098-1124. doi: 10.3109/10715762.2010.498477
12. Lindauer E, Dupuis L, Müller H-P et al (2013) Adipose tissue distribution predicts survival in amyotrophic lateral sclerosis. PLoS One 8:e67783. doi: 10.1371/journal.pone.0067783
13. Solberg R, Longini M, Proietti F et al (2012) Resuscitation with supplementary oxygen induces oxidative injury in the cerebral cortex. Free Radic Biol Med 53:1061-1067. doi: 10.1016/j.freeradbiomed.2012.07.022
14. Milne GL, Yin H, Hardy KD et al (2011) Isoprostane generation and function. Chem Rev 111:5973-5996. doi: 10.1021/cr200160h
15. Roberts LJ, Milne GL (2009) Isoprostanes. J Lipid Res 50:S219-S223. doi: 10.1194/jlr.R800037-JLR200
16. Morrow JD, Hill KE, Burk RF et al (1990) A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U S A 87:9383-9387
17. Roberts LJ II, Morrow JD (2000) Measurement of F2-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 28:505-513. doi: 10.1016/S0891-5849(99)00264-6
18. Niki E (2014) Biomarkers of lipid peroxidation in clinical material. Biochim Biophys Acta 1840:809-817. doi: 10.1016/j.bbagen.2013.03.020
19. Milne GL, Gao B, Terry ES et al (2013) Measurement of F2- isoprostanes and isofurans using gas chromatography-mass spectrometry. Free Radic Biol Med 59:36-44. doi: 10.1016/j.freeradbiomed.2012.09.030
20. Klawitter J, Haschke M, Shokati T et al (2011) Quantification of 15-F2t-isoprostane in human plasma and urine: results from enzyme-linked immunoassay and liquid chromatography/tandem mass spectrometry cannot be compared. Rapid Commun Mass Spectrom RCM 25:463-468. doi: 10.1002/rcm.4871
21. Proudfoot J, Barden A, Mori TA et al (1999) Measurement of urinary F(2)-isoprostanes as markers of in vivo lipid peroxidation-A comparison of enzyme immunoassay with gas chromatography/mass spectrometry. Anal Biochem 272:209-215. doi: 10.1006/abio.1999.4187
22. Lee C-YJ, Jenner AM, Halliwell B (2004) Rapid preparation of human urine and plasma samples for analysis of F2-isoprostanes by gas chromatography-mass spectrometry. Biochem Biophys Res Commun 320:696-702. doi: 10.1016/j.bbrc.2004. 06.015
23. Mas E, Michel F, Guy A et al (2008) Quantification of urinary F2-isoprostanes with 4(RS)-F4t-neuroprostane as an internal standard using gas chromatography-mass spectrometry Application to polytraumatized patients. J Chromatogr B Analyt Technol Biomed Life Sci 872:133-140. doi: 10.1016/j.jchromb.2008.07.037
24. Sterz K, Scherer G, Ecker J (2012) A simple and robust UPLC-SRM/MS method to quantify urinary eicosanoids. J Lipid Res 53:1026-1036. doi: 10.1194/jlr.D023739
25. Medina S, Domínguez-Perles R, Gil JI et al (2012) A ultra-pressure liquid chromatography/triple quadrupole tandem mass spectrometry method for the analysis of 13 eicosanoids in human urine and quantitative 24 hour values in healthy volunteers in a controlled constant diet. Rapid Commun Mass Spectrom RCM 26:1249-1257. doi: 10.1002/rcm.6224
26. Rook D, Schierbeek H, van der Eijk AC et al (2012) Resuscitation of very preterm infants with 30 % vs. 65 % oxygen at birth: study protocol for a randomized controlled trial. Trials 13:65
27. Food and Drug Administration (FDA) (2001) Guidance for industry: bioanalytical method validation
28. Yan W, Byrd GD, Ogden MW (2007) Quantitation of isoprostane isomers in human urine from smokers and nonsmokers by LC-MS/MS. J Lipid Res 48:1607-1617. doi: 10.1194/jlr.M700097-JLR200
29. Masoodi M, Nicolaou A (2006) Lipidomic analysis of twenty-seven prostanoids and isoprostanes by liquid chromatography/electrospray tandem mass spectrometry. Rapid Commun Mass Spectrom RCM 20:3023-3029. doi: 10.1002/rcm.2697
30. Prasain JK, Arabshahi A, Taub PR et al (2013) Simultaneous quantification of F2-isoprostanes and prostaglandins in human urine by liquid chromatography tandem-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 913-914:161-168. doi: 10.1016/j.jchromb.2012.12.009
31. Levison BS, Zhang R, Wang Z et al (2013) Quantification of fatty acid oxidation products using online high-performance liquid chromatography tandem mass spectrometry. Free Radic Biol Med 59:2-13. doi: 10.1016/j.freeradbiomed. 2013.03.001
32. Janagap S, Azeredo R, Nguyen T-T et al (2012) Development of an extraction method for the determination of prostaglandins in biological tissue samples using liquid chromatography-tandem mass spectrometry: application to gonads of Atlantic cod (Gadus morhua). Anal Chim Acta 749:51-55. doi: 10.1016/j.aca.2012.08.039
33. Langhorst ML, Hastings MJ, Yokoyama WH et al (2010) Determination of F2-isoprostanes in urine by online solid phase extraction coupled to liquid chromatography with tandem mass spectrometry. J Agric Food Chem 58:6614-6620. doi: 10.1021/jf101146q
34. Zhang H, Il'yasova D, Sztaray J et al (2010) Quantification of the oxidative damage biomarker 2,3-dinor-8-isoprostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry. Anal Biochem 399:302-304. doi: 10.1016/j.ab.2009.12.024
35. Strassburg K, Huijbrechts AML, Kortekaas KA et al (2012) Quantitative profiling of oxylipins through comprehensive LC-MS/MS analysis: application in cardiac surgery. Anal Bioanal Chem 404:1413-1426. doi: 10.1007/s00216-012-6226-x
36. Ceriotti F (2012) Establishing pediatric reference intervals: a challenging task. Clin Chem 58:808-810. doi: 10.1373/clinchem.2012.183483
37. Colantonio DA, Kyriakopoulou L, Chan MK et al (2012) Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children. Clin Chem 58:854-868. doi: 10.1373/clinchem.2011.177741
38. Yan Z, Mas E, Mori TA et al (2010) A significant proportion of F2-isoprostanes in human urine are excreted as glucuronide conjugates. Anal Biochem 403:126-128. doi: 10.1016/j.ab.2010.04.016
39. Allegaert K, Vanhaesebrouck S, Verbesselt R, van den Anker JN (2009) In vivo glucuronidation activity of drugs in neonates: extensive interindividual variability despite their young age. Ther Drug Monit 31:411-415. doi: 10.1097/FTD.0b013e3181a8cc0a
40. Gallini F, Maggio L, Romagnoli C et al (2000) Progression of renal function in preterm neonates with gestational age∈<∈or=32 weeks. Pediatr Nephrol Berl Ger 15:119-124